Van Lanschot Kempen Investment Management N.V. Acquires 6,702 Shares of Intuitive Surgical, Inc. $ISRG

Key Points

• Van Lanschot Kempen Investment Management N.V. increased its stake in Intuitive Surgical, Inc. by 28%, owning 30,635 shares valued at approximately $15.17 million as reported in its latest SEC filing.
• A number of hedge funds also notably increased their positions, with Chilton Capital Management LLC boosting their stake by 614.3%, indicating strong interest in the company among institutional investors.
• Intuitive Surgical recently reported better-than-expected earnings with an EPS of $2.19, surpassing analysts' forecasts of $1.93, and a revenue of $2.44 billion, reflecting significant year-over-year growth.

Van Lanschot Kempen Investment Management N.V. raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 28.0% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 30,635 shares of the medical equipment provider's stock after acquiring an additional 6,702 shares during the quarter. Van Lanschot Kempen Investment Management N.V.'s holdings in Intuitive Surgical were worth $15,173,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in ISRG. Brighton Jones LLC boosted its stake in Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock valued at $1,916,000 after acquiring an additional 731 shares during the last quarter. Bank Pictet & Cie Europe AG boosted its stake in Intuitive Surgical by 0.5% in the fourth quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider's stock valued at $99,678,000 after acquiring an additional 883 shares during the last quarter. TD Waterhouse Canada Inc. boosted its stake in Intuitive Surgical by 25.5% in the fourth quarter. TD Waterhouse Canada Inc. now owns 28,416 shares of the medical equipment provider's stock valued at $14,831,000 after acquiring an additional 5,765 shares during the last quarter. OneDigital Investment Advisors LLC boosted its stake in Intuitive Surgical by 0.8% in the fourth quarter. OneDigital Investment Advisors LLC now owns 14,947 shares of the medical equipment provider's stock valued at $7,802,000 after acquiring an additional 118 shares during the last quarter. Finally, J. Safra Sarasin Holding AG boosted its stake in Intuitive Surgical by 66.8% in the fourth quarter. J. Safra Sarasin Holding AG now owns 10,409 shares of the medical equipment provider's stock valued at $5,433,000 after acquiring an additional 4,168 shares during the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts recently commented on the stock. Deutsche Bank Aktiengesellschaft cut shares of Intuitive Surgical from a "hold" rating to a "sell" rating and dropped their price target for the company from $515.00 to $440.00 in a research note on Monday, June 9th. Erste Group Bank restated a "hold" rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Truist Financial upped their price target on shares of Intuitive Surgical from $590.00 to $600.00 and gave the company a "buy" rating in a research note on Wednesday, July 23rd. Zacks Research cut shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research note on Wednesday. Finally, Evercore ISI upped their price target on shares of Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a research note on Tuesday, July 8th. Thirteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of "Moderate Buy" and an average target price of $595.95.

Insider Buying and Selling

In other news, EVP Myriam Curet sold 4,500 shares of the stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the transaction, the executive vice president owned 353 shares of the company's stock, valued at $173,845.44. This represents a 92.73% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Mark Brosius sold 216 shares of the stock in a transaction on Friday, June 6th. The stock was sold at an average price of $563.11, for a total transaction of $121,631.76. Following the completion of the transaction, the senior vice president directly owned 907 shares in the company, valued at $510,740.77. The trade was a 19.23% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 15,839 shares of company stock valued at $7,896,972. Company insiders own 0.70% of the company's stock.

Intuitive Surgical Stock Performance

Intuitive Surgical stock traded up $6.28 during midday trading on Friday, reaching $476.16. 2,023,902 shares of the stock were exchanged, compared to its average volume of 1,973,062. The company's fifty day moving average is $504.42 and its 200-day moving average is $522.06. The firm has a market cap of $170.69 billion, a PE ratio of 66.41, a PEG ratio of 4.92 and a beta of 1.59. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. The business had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. Intuitive Surgical's revenue was up 21.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.78 EPS. On average, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.